Francis Willard Sarena Insider Trading $FPRX FIVE PRIME THERAPEUTICS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Francis Willard Sarena.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Francis Willard Sarena. Francis Willard Sarena is Exec Dir/Chief Legal Off/Secy in PDL BIOPHARMA, INC. ($PDLI) and VP/Gen Counsel/Secy in PDL BIOPHARMA, INC. ($PDLI) and Chief Strategy Officer in FIVE PRIME THERAPEUTICS INC ($FPRX) and EVP, Gen Counsel & Secretary in FIVE PRIME THERAPEUTICS INC ($FPRX) and EVP, Gen Counsel and Secretary in FIVE PRIME THERAPEUTICS INC ($FPRX) and SVP, Gen Counsel & Secretary in FIVE PRIME THERAPEUTICS INC ($FPRX).

Francis Willard Sarena in FIVE PRIME THERAPEUTICS, INC.

Trading Symbol: FPRX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Francis Willard Sarena: Chief Strategy Officer, EVP, Gen Counsel and Secretary, EVP, Gen Counsel & Secretary, SVP, Gen Counsel & Secretary
Holdings: 121,542 shares
Current Value: $5,515,576
Latest Transaction: Apr 19 2021
$FPRX Market Capitalization: $1.23B
$FPRX Previous Close: $45.38

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Francis Willard Sarena in FIVE PRIME THERAPEUTICS, INC.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, FPRX, PDLI

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Apr 19 2021	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Option Exercise	D	5.25	90,000	472,500	0
Apr 19 2021	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Option Exercise	D	5.25	90,000	472,500	0
Apr 19 2021	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Option Exercise	D	11.97	58,000	694,260	0
Apr 19 2021	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Option Exercise	D	18.69	45,000	841,050	0
Apr 19 2021	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Option Exercise	D	19.25	75,000	1,443,750	0
Apr 19 2021	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Option Exercise	D	11.14	25,521	284,304	0
Apr 19 2021	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Option Exercise	D	10.77	3,209	34,561	0
Apr 19 2021	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Option Exercise	D	7.26	12,063	87,577	0
Apr 19 2021	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Option Exercise	D	5.54	9,142	50,647	0
Apr 19 2021	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Option Exercise	D	8.49	4,747	40,302	0
Apr 19 2021	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Sell	D	38.00	795	30,210	0	795 to 0 (-100.00 %)
Apr 19 2021	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Sell	D	38.00	795	30,210	0	795 to 0 (-100.00 %)
Apr 19 2021	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Sell	D	38.00	795	30,210	0	795 to 0 (-100.00 %)
Apr 19 2021	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Sell	D	38.00	169,468	6,439,784	0	169.5 K to 0 (-100.00 %)
Apr 19 2021	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Grant	A	0.00	66,000	0	169,468	103.5 K to 169.5 K (+63.79 %)
Apr 19 2021	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Gift	G	0.00	14,174	0	103,468	117.6 K to 103.5 K (-12.05 %)
Apr 19 2021	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Gift	G	0.00	2,460	0	117,642	120.1 K to 117.6 K (-2.05 %)
Apr 19 2021	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Gift	G	0.00	1,440	0	120,102	121.5 K to 120.1 K (-1.18 %)
Apr 19 2021	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Gift	G	0.00	795	0	795	0 to 795
Apr 19 2021	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Gift	G	0.00	795	0	795	0 to 795
Apr 19 2021	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Gift	G	0.00	795	0	795	0 to 795
Apr 19 2021	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Gift	G	0.00	2,385	0	121,542	123.9 K to 121.5 K (-1.92 %)
Mar 02 2021	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Payment of Exercise	F	22.23	1,158	25,742	123,433	124.6 K to 123.4 K (-0.93 %)
Feb 26 2021	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Payment of Exercise	F	23.08	1,653	38,151	124,591	126.2 K to 124.6 K (-1.31 %)
Feb 26 2021	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Payment of Exercise	F	25.71	5,100	131,121	126,244	131.3 K to 126.2 K (-3.88 %)
Dec 15 2020	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Option Exercise	M	0.00	22,000	0	0
Dec 15 2020	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Payment of Exercise	F	16.14	11,583	186,950	126,427	138 K to 126.4 K (-8.39 %)
Dec 15 2020	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Buy	M	0.00	22,000	0	138,010	116 K to 138 K (+18.96 %)
Feb 26 2020	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Option Exercise	A	5.25	90,000	472,500	90,000
Feb 26 2020	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Option Exercise	A	5.25	90,000	472,500	90,000
Feb 26 2020	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Payment of Exercise	F	4.83	1,304	6,298	105,011	106.3 K to 105 K (-1.23 %)
Feb 26 2020	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Payment of Exercise	F	4.87	1,863	9,073	106,315	108.2 K to 106.3 K (-1.72 %)
Feb 26 2020	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Grant	A	0.00	15,000	0	108,178	93.2 K to 108.2 K (+16.10 %)
Feb 26 2020	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Grant	A	0.00	15,000	0	93,178	78.2 K to 93.2 K (+19.19 %)
Feb 06 2020	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Payment of Exercise	F	5.13	4,070	20,879	78,178	82.2 K to 78.2 K (-4.95 %)
Sep 04 2019	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Payment of Exercise	F	5.43	2,811	15,264	82,248	85.1 K to 82.2 K (-3.30 %)
Jun 26 2019	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Option Exercise	A	0.00	44,000	0	44,000
Feb 27 2019	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Option Exercise	A	11.97	58,000	694,260	58,000
Feb 27 2019	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Payment of Exercise	F	11.95	1,194	14,268	82,955	84.1 K to 83 K (-1.42 %)
Feb 27 2019	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Grant	A	0.00	10,000	0	84,149	74.1 K to 84.1 K (+13.49 %)
Feb 07 2019	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Payment of Exercise	F	11.43	2,996	34,244	74,149	77.1 K to 74.1 K (-3.88 %)
Oct 02 2018	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Payment of Exercise	F	13.92	954	13,280	77,145	78.1 K to 77.1 K (-1.22 %)
Oct 02 2018	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Grant	A	0.00	1,923	0	78,099	76.2 K to 78.1 K (+2.52 %)
Sep 05 2018	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Payment of Exercise	F	14.00	2,810	39,340	76,177	79 K to 76.2 K (-3.56 %)
Feb 28 2018	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Option Exercise	A	18.69	45,000	841,050	45,000
Feb 28 2018	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Grant	A	0.00	7,000	0	78,987	72 K to 79 K (+9.72 %)
Sep 07 2017	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Payment of Exercise	F	34.34	3,131	107,519	71,987	75.1 K to 72 K (-4.17 %)
Mar 03 2017	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Payment of Exercise	F	44.77	19,784	885,730	75,118	94.9 K to 75.1 K (-20.85 %)
Feb 09 2017	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Option Exercise	A	45.38	45,000	2,042,100	45,000
Feb 09 2017	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Grant	A	0.00	5,768	0	94,902	89.1 K to 94.9 K (+6.47 %)
Feb 09 2017	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Grant	A	0.00	10,310	0	89,134	78.8 K to 89.1 K (+13.08 %)
Jan 18 2017	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Option Exercise	M	5.54	3,636	20,143	9,142
Jan 18 2017	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Sell	S	47.39	3,636	172,310	78,824	82.5 K to 78.8 K (-4.41 %)
Jan 18 2017	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Buy	M	5.54	3,636	20,143	82,460	78.8 K to 82.5 K (+4.61 %)
Jan 05 2017	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Payment of Exercise	F	48.60	2,442	118,681	78,824	81.3 K to 78.8 K (-3.00 %)
Nov 30 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Option Exercise	M	5.54	1,710	9,473	12,778
Nov 30 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Sell	S	60.14	1,710	102,839	81,266	83 K to 81.3 K (-2.06 %)
Nov 30 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Buy	M	5.54	1,710	9,473	82,976	81.3 K to 83 K (+2.10 %)
Nov 28 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Option Exercise	M	5.54	10,264	56,863	14,488
Nov 28 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Option Exercise	M	6.89	10,925	75,273	0
Nov 28 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Option Exercise	M	6.89	13,465	92,774	10,925
Nov 28 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Sell	S	60.48	21,189	1,281,511	81,266	102.5 K to 81.3 K (-20.68 %)
Nov 28 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Buy	M	5.54	10,264	56,863	102,455	92.2 K to 102.5 K (+11.13 %)
Nov 28 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Buy	M	6.89	10,925	75,273	92,191	81.3 K to 92.2 K (+13.44 %)
Nov 28 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Sell	S	60.23	13,465	810,997	81,266	94.7 K to 81.3 K (-14.21 %)
Nov 28 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Buy	M	6.89	13,465	92,774	94,731	81.3 K to 94.7 K (+16.57 %)
Sep 12 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Option Exercise	A	49.54	35,000	1,733,900	35,000
Sep 12 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	Chief Strategy Offi ...	Grant	A	0.00	7,000	0	81,266	74.3 K to 81.3 K (+9.43 %)
Sep 01 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	EVP, Gen Counsel an ...	Payment of Exercise	F	44.74	19,568	875,472	74,266	93.8 K to 74.3 K (-20.85 %)
Aug 29 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	EVP, Gen Counsel an ...	Option Exercise	A	43.71	60,000	2,622,600	60,000
Aug 29 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	EVP, Gen Counsel an ...	Grant	A	0.00	10,000	0	93,834	83.8 K to 93.8 K (+11.93 %)
Mar 31 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	EVP, Gen Counsel an ...	Option Exercise	M	8.49	5,550	47,120	4,747
Mar 31 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	EVP, Gen Counsel an ...	Option Exercise	M	8.49	3,524	29,919	10,297
Mar 31 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	EVP, Gen Counsel an ...	Option Exercise	M	8.49	926	7,862	0
Mar 31 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	EVP, Gen Counsel an ...	Sell	S	40.01	5,550	222,056	83,834	89.4 K to 83.8 K (-6.21 %)
Mar 31 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	EVP, Gen Counsel an ...	Buy	M	8.49	5,550	47,120	89,384	83.8 K to 89.4 K (+6.62 %)
Mar 31 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	EVP, Gen Counsel an ...	Sell	S	40.00	4,450	178,000	83,834	88.3 K to 83.8 K (-5.04 %)
Mar 31 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	EVP, Gen Counsel an ...	Buy	M	8.49	4,450	37,781	88,284	83.8 K to 88.3 K (+5.31 %)
Jan 29 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	EVP, Gen Counsel & ...	Option Exercise	M	8.49	1,513	12,845	926
Jan 29 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	EVP, Gen Counsel & ...	Option Exercise	M	5.54	7,768	43,035	24,752
Jan 29 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	EVP, Gen Counsel & ...	Option Exercise	M	7.26	7,449	54,080	12,063
Jan 29 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	EVP, Gen Counsel & ...	Option Exercise	M	10.77	3,791	40,829	3,209
Jan 29 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	EVP, Gen Counsel & ...	Option Exercise	M	11.14	9,479	105,596	25,521
Jan 29 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	EVP, Gen Counsel & ...	Sell	S	35.00	1,513	52,955	83,570	85.1 K to 83.6 K (-1.78 %)
Jan 29 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	EVP, Gen Counsel & ...	Buy	M	8.49	1,513	12,845	85,083	83.6 K to 85.1 K (+1.81 %)
Jan 29 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	EVP, Gen Counsel & ...	Sell	S	34.73	7,768	269,783	83,570	91.3 K to 83.6 K (-8.50 %)
Jan 29 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	EVP, Gen Counsel & ...	Buy	M	5.54	7,768	43,035	91,338	83.6 K to 91.3 K (+9.30 %)
Jan 29 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	EVP, Gen Counsel & ...	Sell	S	35.11	7,449	261,534	83,570	91 K to 83.6 K (-8.18 %)
Jan 29 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	EVP, Gen Counsel & ...	Buy	M	7.26	7,449	54,080	91,019	83.6 K to 91 K (+8.91 %)
Jan 29 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	EVP, Gen Counsel & ...	Sell	S	35.31	3,791	133,860	83,570	87.4 K to 83.6 K (-4.34 %)
Jan 29 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	EVP, Gen Counsel & ...	Buy	M	10.77	3,791	40,829	87,361	83.6 K to 87.4 K (+4.54 %)
Jan 29 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	EVP, Gen Counsel & ...	Sell	S	36.13	2,584	93,360	83,570	86.2 K to 83.6 K (-3.00 %)
Jan 29 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	EVP, Gen Counsel & ...	Sell	S	35.55	6,895	245,117	86,154	93 K to 86.2 K (-7.41 %)
Jan 29 2016	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	EVP, Gen Counsel & ...	Buy	M	11.14	9,479	105,596	93,049	83.6 K to 93 K (+11.34 %)
Aug 21 2015	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	EVP, Gen Counsel & ...	Grant	A	0.00	75,000	0	83,570	8.6 K to 83.6 K (+875.15 %)
Aug 19 2015	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	SVP, Gen Counsel & ...	Option Exercise	A	19.25	75,000	1,443,750	75,000
May 04 2015	FPRX	FIVE PRIME THERAPE ...	Sarena Francis Willard	SVP, Gen Counsel & ...	Grant	A	0.00	6,110	0	8,570	2.5 K to 8.6 K (+248.37 %)

Page: 1